학술논문

Changes in typical beliefs in response to complicated grief treatment
Document Type
article
Source
Depression and Anxiety. 37(1)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Psychology
Behavioral and Social Science
Prevention
Clinical Research
Mental Health
Evaluation of treatments and therapeutic interventions
6.1 Pharmaceuticals
Bereavement
Citalopram
Depression
Female
Grief
Humans
International Classification of Diseases
Male
Middle Aged
Psychotherapy
Suicidal Ideation
Surveys and Questionnaires
Treatment Outcome
assessment
diagnosis
cognition
grief
bereavement
complicated grief
suicide
self harm
treatment
assessment/diagnosis
grief/bereavement/complicated grief
suicide/self harm
Psychiatry
Clinical sciences
Clinical and health psychology
Social and personality psychology
Language
Abstract
BackgroundProlonged grief disorder (PGD) is a new diagnosis in the 11th edition of the International Classification of Diseases, estimated to affect 1 in 10 bereaved people and causing significant distress and impairment. Maladaptive thoughts play an important role in PGD. We have previously validated the typical beliefs questionnaire (TBQ), which contains five kinds of thinking commonly seen in PGD: protesting the death, negative thoughts about the world, needing the person, less grief is wrong, and grieving too much. The current paper examines the role of maladaptive cognition as measured by the TBQ in PGD and its change with treatment.MethodsAmong participants in a multisite clinical trial including 394 adults, we examined (a) the relationship between maladaptive thoughts at baseline and treatment outcomes, (b) the relationship between maladaptive thoughts and suicidality at baseline and posttreatment, and (c) the effect of treatment with and without complicated grief therapy (CGT) on maladaptive thinking.ResultsTBQ scores were associated with treatment outcomes and were strongly related to suicidal thinking before and after treatment. TBQ scores showed significantly greater reduction in participants who received CGT with citalopram versus citalopram alone (adjusted mean standard error [SE] difference, -2.45 [0.85]; p = .004) and those who received CGT with placebo versus placebo alone (adjusted mean [SE] difference, -3.44 [0.90]; p